Alzheimer diseasedementiadirect health care costBackground: Although one third of Medicare beneficiaries are enrolled in Medicare Advantage (MA) plans, there is limited information about the cost of treating Alzheimer disease and related dementias (ADRD) in these settings. Objective: The obje...
The first drug purporting to slow the advance of Alzheimer's disease is likely to cost the U.S. health care system billions annually even as it remains out of reach for many of the lower-income seniors most likely to suffer from dementia. Medicare and Medicaid patients will make up 92% o...
Objective The objectives of this analysis were to examine how patients’ global severity with Alzheimer’s disease (AD) relates to costs of care and explore the incremental effects of global severity measured by the clinical dementia rating (CDR) scale on these costs for patients in Spain. Method...
Alzheimer's disease is the most common form of dementia. The aim of this study was to determine the dependence between the quality of the caregiver-patient relationship and the psychological costs the caregiver bears during the caregiving period. This study encompassed 292 caregivers (104 partners,...
The costs of care for patients with Alzheimer's disease are correlated with key measures of disease severity. This relationship is important in the economic evaluation of new treatments and is used to translate treatment efficacy into effects on costs through economic modeling. We aimed to identify...
The annual consumption and costs of the health care resources used by ambulatory Alzheimer's disease patients were estimated. Patients were classified according to the degree of severity of the disease using Folstein's Mini Mental State Examination scale. The sociodemographic characteristics of both pati...
Background and ObjectivesPrior research has documented that Alzheimer's disease (AD) is associated with increased costs from comorbid conditions. However, little is known about medical resource utilization and costs among AD patients prior to the onset of cognitive symptoms. This study estimates excess...
Certain hereditary diseases in your family—like Alzheimer's or diabetes—could make it more likely that you’ll have long-term care needs in the future. A thoughtful long-term care coverage decision is all about balance—weighing what you can afford, the kind of care you expect, and the ...
Alzheimer's disease (AD) is a neurodegenerative disorder incurring significant social and economic costs. This study uses a US administrative claims database to evaluate the effect of AD on direct healthcare costs and utilization, and to identify the most common reasons for AD patients' emergency ...
This study aims to compare the downstream costs and healthcare utilization associated with using low-dose computed tomography (LDCT) for lung cancer screening in patients with and without Alzheimer's disease and related dementias (ADRD).#Based on data from IBM MarketScan Commercial Claims Databases ...